Article
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy.
Journal of virology - 1 Feb 2004
Biswas Preetha, Jiang Xi, Pacchia Annmarie L, Dougherty Joseph P, Peltz Stuart W
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) utilizes a distinctive form of gene regulation as part of its life cycle, termed programmed -1 ribosomal frameshifting, to produce the required ratio of the Gag and Gag-Pol polyproteins. We carried out a sequence comparison of 1,000 HIV-1 sequences at the slippery site (UUUUUUA) and found that the site is invariant, which is somewhat surprising for a virus known for its...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
